Skip to main content
Equibles

NRX · NurExone Biologic Inc. · Insider Trading

Use NRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.50 CAD +0.025 (+5.26%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked
Market Cap
46.02M CAD
Shares
92.05M
Volume · Nov 6 10.53K Avg daily vol (3M) 22.83K

Transactions in NurExone Biologic Inc. securities by its insiders (directors, officers and significant shareholders) as filed on SEDI, the Canadian Securities Administrators' insider disclosure system.

Insider transactions

Insider transactions as filed on SEDI, each amended transaction at its newest amendment only. Capture began with about the year before its first read and grows daily, so older history is not included. Amounts are signed (negative for a disposition) and counted in the units of the security named, which may be options, share units or warrants rather than shares. Prices are in the stated currency. Holding after is the insider's balance of that security after the transaction, as filed.

Insider transactions filed on SEDI, the Canadian Securities Administrators' System for Electronic Disclosure by Insiders
Transaction dateInsiderTransactionSecurityAmountPriceHolding afterFiled
2026-07-28 Stolick, David Director of Issuer Opening Balance-Initial SEDI Report OptionsUnderlying: Common Shares 0 129,000Direct 2026-09-18
2026-01-30 Gabbai, Eyal Director of Issuer Opening Balance-Initial SEDI Report OptionsUnderlying: Common Shares 0 129,200Direct 2026-09-18
2025-12-22 Richardson, James Angus Wilson (Bilkstys-) Director of Issuer Acquisition or disposition in the public market Common Shares -10,000 0.68 CAD 168,274Direct 2025-12-22
2025-12-02 Richardson, James Angus Wilson (Bilkstys-) Director of Issuer Acquisition or disposition in the public market Common Shares +1,500 0.69 CAD 178,274Direct 2025-12-03
2025-12-01 Richardson, James Angus Wilson (Bilkstys-) Director of Issuer Acquisition or disposition in the public market Common Shares +5,000 0.69 CAD 176,774Direct 2025-12-01
2025-11-27 Drucker, Yoram Director of Issuer Grant of rightsAmendment 2 Restricted Share UnitsUnderlying: Common Shares +200,000 0.71 CAD 550,000Direct 2026-09-15
2025-11-27 Ovadya, Eran Senior Officer of Issuer Grant of rightsAmendment 2 Restricted Share UnitsUnderlying: Common Shares +100,000 0.71 CAD 450,000Direct 2026-09-15
2025-11-27 Shaltiel, Lior Director of Issuer Grant of rightsAmendment 2 Restricted Share UnitsUnderlying: Common Shares +100,000 0.71 CAD 450,000Direct 2026-09-15

8 transactions between 2025-11-27 and 2026-07-28. Checked 2026-11-08 16:51 UTC.

Showing 1–8 of 8 transactions